News Feed Item

Heart Hospital of Austin First in Texas to Implant New Portico™ Re-sheathable Transcatheter Aortic Valve System as Part of Clinical Trial

AUSTIN, Texas, Aug. 27, 2014 /PRNewswire/ -- On Aug. 26, 2014, physicians at Heart Hospital of Austin became the first in Texas to implant the new Portico™ Re-sheathable Transcatheter Aortic Valve System—an innovative, repositionable aortic heart valve and delivery system. Heart Hospital of Austin is part of the PORTICO trial, a nationwide clinical study to examine the effectiveness of the new heart valve. The Portico valve was used during a catheter-based valve replacement procedure known as a transcatheter aortic valve replacement (TAVR), which is designed to treat patients with severe aortic stenosis who are not candidates for open-heart surgery due to advanced age, or because they are too ill or suffering from additional medical conditions. The TAVR procedure was first performed in Central Texas at Heart Hospital of Austin in February 2012.

Faraz Kerendi, M.D., a cardiothoracic surgeon at Cardiothoracic and Vascular Surgeons, and Frank Zidar, M.D., an interventional cardiologist at Heart Hospital of Austin and with Austin Heart, implanted the Portico valve. The patient, a 68-year-old man, was identified as a candidate for the new Portico valve by physicians at the Heart Valve Clinic at Heart Hospital of Austin, a clinic specifically designed to evaluate and treat patients with valvular disease and disorders. Drs. Kerendi and Zidar are principal investigators of the PORTICO trial at Heart Hospital of Austin.

"The procedure was very successful," Dr. Kerendi said. "The ability to fully resheath and precisely reposition the Portico valve prior to final valve deployment was very beneficial, as it helped achieve accurate placement and minimize procedural risk for the patient."

The Portico valve is the first fully repositionable transcatheter valve—allowing the physician to accurately place the valve at the implant site, via a catheter, or retrieve it before the valve is fully deployed and released from the delivery system. The ability to reposition the valve helps physicians place the valve more accurately, reducing the risk for patients. The self-expanding Portico valve was developed to maintain blood flow similar to that of a natural valve.

"We are excited to have the opportunity to participate in this trial, as this valve has the potential to greatly impact patients and improve their quality of life," Dr. Zidar said. "This unique valve design allows the device to be assessed after implantation and, if necessary, repositioned to optimize its function."

Artificial aortic heart valves are used to treat patients with symptomatic severe aortic stenosis, a condition in which the opening of the aortic valve becomes narrow, restricting blood flow from the heart to the body and causing the heart to work harder. Over time, the valve can become calcified, preventing it from opening and releasing blood properly. Symptoms of severe aortic stenosis include fatigue, dizziness or fainting, and chest pain or discomfort. It can also cause pressure to "back up" into the lungs, resulting in shortness of breath. Left untreated, this condition is often fatal.

Traditional heart valve replacement requires that patients undergo open-heart surgery—a more invasive approach that results in a longer recovery process. Because of this, some patients with aortic stenosis are not considered candidates for this type of treatment.

The TAVR procedure consists of inserting a valve—which is compressed down to the size of a pencil—through the groin via a catheter, up to the aorta. After the catheter is advanced through the aorta and aortic valve, the valve is positioned and then opened with a balloon. TAVR results in a shorter recovery time—one to two weeks, versus six to eight weeks for traditional surgery—and it prevents the need for physicians to utilize a heart bypass machine, allowing the patient's heart to beat on its own throughout the entire procedure.

The Portico transcatheter aortic heart valve system is limited to investigational use in the United States, and the PORTICO trial is being conducted under an Investigational Device Exemption from the U.S. Food and Drug Administration.

Heart Hospital of Austin is one of 40 sites in the United States participating in the PORTICO trial. Enrolled patients will undergo a TAVR procedure receiving either a Portico valve or another TAVR valve that is commercially available in the United States. Additionally, the trial will collect information on patients who are having a Portico valve placed inside an existing, degenerated surgical valve. This valve-in-valve registry will include patients in the trial who previously had valve replacement surgery and are now having a Portico valve placed inside an existing artificial valve without removing it.

For additional information about the Portico valve, visit SJMPortico.com, and for the PORTICO trial visit ClinicalTrials.gov.

Media Contacts:
Erin Ochoa and Lisa Candido
Elizabeth Christian & Associates Public Relations

SOURCE Heart Hospital of Austin

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
The IoT Will Grow: In what might be the most obvious prediction of the decade, the IoT will continue to expand next year, with more and more devices coming online every single day. What isn’t so obvious about this prediction: where that growth will occur. The retail, healthcare, and industrial/supply chain industries will likely see the greatest growth. Forrester Research has predicted the IoT will become “the backbone” of customer value as it continues to grow. It is no surprise that retail is ...
Digital Transformation: Preparing Cloud & IoT Security for the Age of Artificial Intelligence. As automation and artificial intelligence (AI) power solution development and delivery, many businesses need to build backend cloud capabilities. Well-poised organizations, marketing smart devices with AI and BlockChain capabilities prepare to refine compliance and regulatory capabilities in 2018. Volumes of health, financial, technical and privacy data, along with tightening compliance requirements by...
Business professionals no longer wonder if they'll migrate to the cloud; it's now a matter of when. The cloud environment has proved to be a major force in transitioning to an agile business model that enables quick decisions and fast implementation that solidify customer relationships. And when the cloud is combined with the power of cognitive computing, it drives innovation and transformation that achieves astounding competitive advantage.
Evan Kirstel is an internationally recognized thought leader and social media influencer in IoT (#1 in 2017), Cloud, Data Security (2016), Health Tech (#9 in 2017), Digital Health (#6 in 2016), B2B Marketing (#5 in 2015), AI, Smart Home, Digital (2017), IIoT (#1 in 2017) and Telecom/Wireless/5G. His connections are a "Who's Who" in these technologies, He is in the top 10 most mentioned/re-tweeted by CMOs and CIOs (2016) and have been recently named 5th most influential B2B marketeer in the US. H...
How is DevOps going within your organization? If you need some help measuring just how well it is going, we have prepared a list of some key DevOps metrics to track. These metrics can help you understand how your team is doing over time. The word DevOps means different things to different people. Some say it a culture and every vendor in the industry claims that their tools help with DevOps. Depending on how you define DevOps, some of these metrics may matter more or less to you and your team.
DevOpsSummit New York 2018, colocated with CloudEXPO | DXWorldEXPO New York 2018 will be held November 11-13, 2018, in New York City. Digital Transformation (DX) is a major focus with the introduction of DXWorldEXPO within the program. Successful transformation requires a laser focus on being data-driven and on using all the tools available that enable transformation if they plan to survive over the long term. A total of 88% of Fortune 500 companies from a generation ago are now out of bus...
DXWordEXPO New York 2018, colocated with CloudEXPO New York 2018 will be held November 11-13, 2018, in New York City and will bring together Cloud Computing, FinTech and Blockchain, Digital Transformation, Big Data, Internet of Things, DevOps, AI, Machine Learning and WebRTC to one location.
Dion Hinchcliffe is an internationally recognized digital expert, bestselling book author, frequent keynote speaker, analyst, futurist, and transformation expert based in Washington, DC. He is currently Chief Strategy Officer at the industry-leading digital strategy and online community solutions firm, 7Summits.
@DevOpsSummit New York 2018, colocated with CloudEXPO | DXWorldEXPO New York 2018 will be held November 11-13, 2018, in New York City. From showcase success stories from early adopters and web-scale businesses, DevOps is expanding to organizations of all sizes, including the world's largest enterprises - and delivering real results.
DXWorldEXPO LLC announced today that Dez Blanchfield joined the faculty of CloudEXPO's "10-Year Anniversary Event" which will take place on November 11-13, 2018 in New York City. Dez is a strategic leader in business and digital transformation with 25 years of experience in the IT and telecommunications industries developing strategies and implementing business initiatives. He has a breadth of expertise spanning technologies such as cloud computing, big data and analytics, cognitive computing, m...
Widespread fragmentation is stalling the growth of the IIoT and making it difficult for partners to work together. The number of software platforms, apps, hardware and connectivity standards is creating paralysis among businesses that are afraid of being locked into a solution. EdgeX Foundry is unifying the community around a common IoT edge framework and an ecosystem of interoperable components.
DXWorldEXPO LLC announced today that Kevin Jackson joined the faculty of CloudEXPO's "10-Year Anniversary Event" which will take place on November 11-13, 2018 in New York City. Kevin L. Jackson is a globally recognized cloud computing expert and Founder/Author of the award winning "Cloud Musings" blog. Mr. Jackson has also been recognized as a "Top 100 Cybersecurity Influencer and Brand" by Onalytica (2015), a Huffington Post "Top 100 Cloud Computing Experts on Twitter" (2013) and a "Top 50 C...
Cloud-enabled transformation has evolved from cost saving measure to business innovation strategy -- one that combines the cloud with cognitive capabilities to drive market disruption. Learn how you can achieve the insight and agility you need to gain a competitive advantage. Industry-acclaimed CTO and cloud expert, Shankar Kalyana presents. Only the most exceptional IBMers are appointed with the rare distinction of IBM Fellow, the highest technical honor in the company. Shankar has also receive...
Enterprises have taken advantage of IoT to achieve important revenue and cost advantages. What is less apparent is how incumbent enterprises operating at scale have, following success with IoT, built analytic, operations management and software development capabilities - ranging from autonomous vehicles to manageable robotics installations. They have embraced these capabilities as if they were Silicon Valley startups.
DXWorldEXPO LLC announced today that ICOHOLDER named "Media Sponsor" of Miami Blockchain Event by FinTechEXPO. ICOHOLDER give you detailed information and help the community to invest in the trusty projects. Miami Blockchain Event by FinTechEXPO has opened its Call for Papers. The two-day event will present 20 top Blockchain experts. All speaking inquiries which covers the following information can be submitted by email to [email protected] Miami Blockchain Event by FinTechEXPO also offers s...